Courtney D. DiNardo, Jennifer Marvin-Peek, Sanam Loghavi, Koichi Takahashi, Ghayas C. Issa, Wei-Ying Jen, Naval G. Daver, Patrick K. Reville, Nicholas J. Short, Koji Sasaki, Jillian K. Mullin, Corey A. Bradley, Gautam Borthakur, Abhishek Maiti, Yesid Alvarado, Naveen Pemmaraju, Hussein A. Abbas, Danielle E. Hammond, Fadi Haddad, Guillermo Montalban Bravo, Kelly S. Chien, Musa Yilmaz, Steven M. Kornblau, Elias Jabbour, Farhad Ravandi, Tapan Kadia, Guillermo Garcia-Manero, Marina Y. Konopleva, Hagop M. Kantarjian. "Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy–Ineligible Patients With Isocitrate Dehydrogenase–Mutated AML." Journal of Clinical Oncology, 2025. doi:10.1200/jco-25-00640